Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 USD | -0.62% | -0.81% | -3.04% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.04% | 186B | |
-2.23% | 107B | |
-3.97% | 67.44B | |
+3.16% | 50.03B | |
+16.75% | 47.81B | |
+4.79% | 41.03B | |
+2.83% | 26.85B | |
+3.91% | 25.82B | |
-0.58% | 25.01B | |
+16.55% | 24.74B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Wolfe Research Initiates Coverage on Abbott Laboratories With Underperform Rating